CTIS2023-507137-24-00招募中1 期
A pilot single center, open label trial to assess the impact of doxycycline postexposure prophylaxis on antimicrobial resistance - ITM202302
Institute Of Tropical Medicine0 个研究点目标入组 78 人开始时间: 2023年10月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- Male
入选标准
- •Able and willing to provide written informed consent, Age 18 years old or older, Eligible to take HIV PrEP, Male sex at birth
排除标准
- •Use of any antibiotics in the previous 3 months, Known contra-indications or allergy to doxycycline, gluten or lactose, Currently using or planning to use anticoagulants based on vitamin K antagonism (warfarin, acenocoumarol, fenprocoumon)
研究者
相似试验
已完成
1 期
A single center, open-labeled, pilot study to evaluate the safety and efficacy of cardiac cycle-synchronized electrical lower limb muscle stimulation therapy for cardiovascular diseaseatent heart failure (NYHA class: II-III), ischemic heart disease (CCS class: II-III), peripheral artery disease (Fontaine class: II-IV), pulmonary artery hypertension (WHO class: II-III), and healthy adultJPRN-UMIN000026841Kurume University School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine30
尚未招募
1 期
Biocompatible & Biodegradable Polymeric Skin Grafts for WoundsCTRI/2020/11/029284SASTRA Deemed University
进行中（未招募）
1 期
A pilot study to assess the efficacy and safety of CBD oral solution in addition to standard treatment for pediatric subjects with Developmental and Epileptic EncephalopathyDevelopmental and Epileptic Encephalopathy (DEE)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-001633-14-ITIRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA20
撤回
1 期
A SINGLE CENTER OPEN-LABEL PILOT STUDY TO EVALUATE THE TOLERABILITY AND SAFETY OF A SYNTHETIC SOFT TISSUE IMPLANT MATERIAL IN THE SKIN OF NORMAL VOLUNTEERSTolerability and safety of a new synthetic soft tissue implant material for soft tissue augmentation in healthy volunteers.Surgery - Other surgeryACTRN12607000223437COSMETREND PTY LTD8
已完成
不适用
A single centre, open label trial investigating the absorption, metabolism and excretion of somapacitan after single subcutaneous dosing in healthy male subjectsgroeihormoondeficientiegrowth hormone deficiencyNL-OMON42854ovo Nordisk A/S7